INT267804

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.47
First Reported 2006
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 4
Total Number 4
Disease Relevance 1.45
Pain Relevance 0.51

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

mitochondrion (Pln) protein complex (Pln)
Anatomy Link Frequency
cardiomyocytes 1
Pln (Rattus norvegicus)
Pain Link Frequency Relevance Heat
Dopamine 14 85.12 High High
agonist 11 84.40 Quite High
Gabapentin 12 74.40 Quite High
addiction 4 71.68 Quite High
ischemia 2 5.00 Very Low Very Low Very Low
Opioid 2 5.00 Very Low Very Low Very Low
sSRI 1 5.00 Very Low Very Low Very Low
depression 1 5.00 Very Low Very Low Very Low
Inflammation 1 5.00 Very Low Very Low Very Low
Morphine 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Hypoxia 52 99.16 Very High Very High Very High
Restless Legs Syndrome 218 88.64 High High
Vomiting 4 75.12 Quite High
Disease 4 62.56 Quite High
Renal Disease 6 61.76 Quite High
Fatigue 5 56.68 Quite High
Apoptosis 25 55.36 Quite High
Sleep Disorders 50 50.00 Quite Low
Myocardial Infarction 4 40.52 Quite Low
Lymphatic System Cancer 1 24.28 Low Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Here we proceed as follows, see Figure 2: according to the definition of PLM during sleep (Zucconi et al., 2006) we select LM runs of n???
Gene_expression (definition) of PLM
1) Confidence 0.47 Published 2010 Journal Frontiers in Neuroscience Section Body Doc Link PMC2953451 Disease Relevance 0 Pain Relevance 0.06
In addition, phospholamban (PLB) and ryanodine receptor (RyR) expressions were not altered in hypoxia-reoxygenated cardiomyocytes treated with thiopental.
Gene_expression (expressions) of PLB in cardiomyocytes associated with hypoxia
2) Confidence 0.26 Published 2010 Journal Yonsei Medical Journal Section Body Doc Link PMC2824862 Disease Relevance 0.62 Pain Relevance 0
In addition, in 16 patients, pergolide produced improvements in sleep efficiency (from 61% to 79%) and reduced PLM-I (from 48.9 to 14.5) (Earley et al 1998).
Gene_expression (produced) of PLM
3) Confidence 0.09 Published 2006 Journal Neuropsychiatric Disease and Treatment Section Body Doc Link PMC2671944 Disease Relevance 0.44 Pain Relevance 0.07
Similarly, in 17 patients, pramipexole reduced PLM-I (11.3 vs 73.3 for placebo), and increased total sleep time (374.5 minutes vs 215.4 minutes) and sleep efficiency (77.1% vs 44.5%) (Stiasny-Kolster and Oertel 2004).
Gene_expression (reduced) of PLM
4) Confidence 0.08 Published 2006 Journal Neuropsychiatric Disease and Treatment Section Body Doc Link PMC2671944 Disease Relevance 0.39 Pain Relevance 0.38

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox